3pe1: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3pe1.png|left|200px]] | [[Image:3pe1.png|left|200px]] | ||
{{STRUCTURE_3pe1| PDB=3pe1 | SCENE= }} | {{STRUCTURE_3pe1| PDB=3pe1 | SCENE= }} | ||
===Crystal structure of human protein kinase CK2 alpha subunit in complex with the inhibitor CX-4945=== | ===Crystal structure of human protein kinase CK2 alpha subunit in complex with the inhibitor CX-4945=== | ||
{{ABSTRACT_PUBMED_21870818}} | {{ABSTRACT_PUBMED_21870818}} | ||
| Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
*[[Casein kinase]] | *[[Casein kinase|Casein kinase]] | ||
==Reference== | ==Reference== | ||
Revision as of 11:55, 27 July 2012
Crystal structure of human protein kinase CK2 alpha subunit in complex with the inhibitor CX-4945Crystal structure of human protein kinase CK2 alpha subunit in complex with the inhibitor CX-4945
Template:ABSTRACT PUBMED 21870818
About this StructureAbout this Structure
3pe1 is a 1 chain structure of Casein kinase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Battistutta R, Cozza G, Pierre F, Papinutto E, Lolli G, Sarno S, O'Brien SE, Siddiqui-Jain A, Haddach M, Anderes K, Ryckman DM, Meggio F, Pinna LA. Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical stage for the treatment of cancer. Biochemistry. 2011 Aug 26. PMID:21870818 doi:10.1021/bi2008382
- ↑ Cozza G, Mazzorana M, Papinutto E, Bain J, Elliott M, di Maira G, Gianoncelli A, Pagano MA, Sarno S, Ruzzene M, Battistutta R, Meggio F, Moro S, Zagotto G, Pinna LA. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2. Biochem J. 2009 Jul 15;421(3):387-95. PMID:19432557 doi:10.1042/BJ20090069